Skip to main content
28 November 2018

Welcome to Reach

(L-R) Prof Ganesan Karthikeyan, Prof Kathryn Taubert, Jeremiah Mwangi (Reach Executive Director), Prof Liesl Zhülke, Prof Jonathan Carapetis, Dr Sophie La Vincente (Reach Deputy Executive Director and Head of Country Programmes)
(L-R) Prof Ganesan Karthikeyan, Prof Kathryn Taubert, Jeremiah Mwangi (Reach Executive Director), Prof Liesl Zhülke, Prof Jonathan Carapetis, Dr Sophie La Vincente (Reach Deputy Executive Director and Head of Country Programmes)

We are delighted to welcome you to our new look website. You will have seen our new logo that represents our commitment to stop rheumatic disease in its tracks while sticking with the traditional colours that have brought us this far. Over the last 6 months, we have undertaken some significant changes to our organization. Earlier this year we decided to formally register Reach as a standalone NGO with its headquarters in Geneva, Switzerland. This decision was based on the need to formalise Reach’s partnerships with several key partners in order to better deliver on our goal to reduce the burden of RHD around the world.
 
In May this year, we celebrated the adoption of WHA Resolution 71.14 on rheumatic fever (RF) and rheumatic heart disease (RHD) by member states of the World Health Organization. While the resolution offers a path to eliminating RF and RHD, such a goal cannot be achieved without greater efforts by all partners. Following the adoption of the WHA Resolution there has been increasing demand for technical support for governments to support the implementation of RF/RHD Prevention and Control Programmes.

Since our original foundation as RhEACH in 2013, we have accumulated the knowledge and experience to fill this gap. (You can read more about our history here) As we continue our evolution, we will turn our focus to providing the much-needed technical support and assistance to ministries of health and other partners to fully implement the WHA Resolution. Our work will fall into three broad areas: People, Policy and Programmes. We encourage you to visit the “What We Do” page of our website to find out more about the activities in progress and planned. We remain committed to developing resources for the RHD community to use and encourage you to visit our “resources” page. Over the next year, we aim to expand on these resources to ensure you have the full set of tools needed to support comprehensive RF/RHD programmes.

While headquartered in Geneva, we will continue to maintain offices at our founding institutions, the University of Cape Town in South Africa and at the Telethon Kids Institute in Perth, Australia. Similarly, as a founding partner of RHD Action, we will continue to support its work and the valuable role it has played bringing the RHD community together.

In 2019, we hope to develop new partnerships and deepen the impact of our work. We look forward to working with and supporting your efforts to stop rheumatic heart disease, so please don’t hesitate to be in touch with our team to share your experiences and let us know what is needed where you work to improve the lives of people living with RHD and prevent future cases.

Thank you for your continued engagement with Reach. Together we can stop rheumatic heart disease.
Reach